Metabolic Drivers of MASLD/MASH: Understanding the Disease and Identifying At-Risk Patients

Program Description

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), are becoming more common as rates of obesity, type 2 diabetes, and other cardiometabolic conditions continue to rise. As a result, more patients are at risk for advanced fibrosis, cirrhosis, and other serious liver-related complications. Because many patients remain asymptomatic until later stages, effective management depends on early risk recognition and practical, noninvasive evaluation. Ongoing challenges include delayed diagnosis, inconsistent screening practices, and the terminology shift from NAFLD/NASH to MASLD/MASH, which may affect clinical communication during this transition period. This webinar will review how pharmacists are well positioned to help identify high-risk patients, encourage appropriate screening and follow-up, and reinforce lifestyle and cardiometabolic risk-reduction strategies. This symposium is the first in the MASLD/MASH curriculum.

Target audience: Specialty and health-system pharmacist
Type of activity: Application
Release date: May 31, 2026
Expiration date: May 31, 2027
Learner level: Foundational
Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Explain the epidemiology, metabolic drivers, clinical presentation, and disease burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)
• Identify clinical indicators and high-risk patient populations that may warrant further evaluation for MASLD/MASH
• Apply current guideline recommendations to support screening awareness, patient education, and referral for appropriate evaluation

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number 0290-0000-26-161-H01-P. The activity is available for CE credit through May 31, 2027.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with ineligible companies to disclose:

Faculty

Erenie Guirguis, PharmD, BCPS, FSSHP

Professor of Pharmacy Practice

PGY-1 Residency Program Director

Lloyd L. Gregory School of Pharmacy

Palm Beach Atlantic University

West Palm Beach, FL

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Rose Buszka, PharmD, BCPS, CHCP; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with ineligible companies to disclose.

Any relevant financial relationships listed for these individuals have been mitigated.

At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.

Educational Disclaimer

CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms